NRG CC004

Primary Category:

Cancer Control and Prevention Protocols

Disease Category:

Breast, Gynecologic

Status:

Open

Phase II Double Blind Dose Finding Trial of Bupropion Versus Placebo for Sexual Desire in Women with Breast or Gynecologic Cancer

Eligible for screening study DCP 001

NCT#03180294

This protocol has additional regulatory requirements to be completed prior to registering any patients at your site.  Please contact Amber Boerner at 406-969-6067 or aboerner@mtcancer.org for additional information.